secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inotiv, Inc. (NOTV)
CIK:        0000720154
Form:       8-K
Filed at:   2023-10-19T23:59:59+00:00
Accession:  0001628280-23-034692
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inotiv appoints Terry Coelho to board, replacing Richard Johnson effective Oct 16, 2023
--------------------------------------------------------------------------------

- Richard A. Johnson resigned as director; Terry Coelho appointed as Class II director.
- Coelho also joins Compensation, Audit, and chairs Nominating/Corporate Governance committees.
- Coelho is CFO of Gamida Cell; previously led CinCor Pharma's $190M IPO and its sale to AstraZeneca.
- Director annual cash retainer $55,000; committee chairs/members receive additional retainers.
- Coelho granted 12,911 restricted stock units as initial equity award.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/720154/000162828023034692/0001628280-23-034692-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/720154/000162828023034692/notv-20231016.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-034692

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer